Now livetag icon
The future of market intelligence is here. Meet AI Studio — your AI-powered Similarweb expertLearn morebanner icon
Spectrum Pharmaceuticals, Inc.

一月 2026

  • Home
  • Spectrum Pharmaceuticals, Inc.

一月 2026的Spectrum Pharmaceuticals...市场份额分析

成立年份1987
员工51 - 200
年营收$25M - $50M
sppirx.com
Spectrum Pharmaceuticals, Inc.
Spectrum Pharmaceuticals, Inc.(包含公司地区分支机构)
  • sppirx.com
    sppirx.com
查看更多网站流量和参与度信息

Spectrum Pharmaceuticals, Inc.收入截至 一月 2026为 25M - 50M

Spectrum Pharmaceuticals, Inc.主要域名产生的收入

3 年中Spectrum Pharmaceuticals, Inc.主要域名的收入

Spectrum Pharmaceuticals, Inc.主要域名的收入


Spectrum Pharmaceuticals, Inc.热门域名的总访问量

了解Spectrum Pharmaceuticals, Inc.市场份额和潜在市场覆盖范围。

过去 3 个月的总访问量

无数据可显示

无数据可显示

Spectrum Pharmaceuticals, Inc.热门域名的平均访问时长

分析Spectrum Pharmaceuticals, Inc.参与度指标。

过去 3 个月的平均访问时长

无数据可显示

无数据可显示

Spectrum Pharmaceuticals, Inc.热门域名的平均页面浏览量

了解Spectrum Pharmaceuticals, Inc.如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。

过去 3 个月的平均页面浏览量

无数据可显示

无数据可显示

想要获取更深入的流量洞见?

过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。



Spectrum Pharmaceuticals, Inc. 采用的主要技术

这些是排名前 Spectrum Pharmaceuticals, Inc. 的顶级域名所使用的网站技术(按行业分列)

移动设备 (2)

Meta Viewport

Meta Viewport

人才招聘 (2)

付费广告 (1)

DoubleClick

DoubleClick

视听媒体 (1)

Vimeo

Vimeo

更多技术

8

查看全部

准备好发现优质潜在客户了吗?

借助 Similarweb 销售情报解决方案,确定任意网站使用了哪些技术来设计完美的销售宣传,并缩短销售周期。


Spectrum Pharmaceuticals, Inc. 的新闻与信号

借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。

新闻Bragar Eagel & Squire PC filed suit against Sppirx on Sep 24th '25.SPECTRUM FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds investors of the Class action lawsuit filed against Spectrum Pharmaceuticals, Inc. and Encourages Investors to contact the firm before September 24th.
新闻Srivastava left Sppirx as Global Compliance Officer on Dec 22nd '23.Mr. Srivastava joins BPGbio from Spectrum Pharmaceuticals, a publicly traded biopharmaceutical company, where he held several leadership roles for over five years, including most recently as Global Compliance Officer.
新闻Sppirx has issues with possible breaches of fiduciary duty and other violations of law.Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Spectrum Pharmaceuticals, Inc. ("Spectrum Pharmaceuticals" or the "Company") SPPI, in connection with its acquisition by Assertio Holdings, Inc.

查看 Spectrum Pharmaceuticals, Inc. 的所有信号

让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。